Effect of comorbidity on mortality in patients with peptic ulcer bleeding: Systematic review and meta-analysis

American Journal of Gastroenterology

Volumn 108, Issue 3, 2013, Pages 331-345

  Leontiadis, Grigorios I ^a   Molloy Bland, Michael ^a   Moayyedi, Paul ^b   Howden, Colin W ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b Research Evaluation Unit   (United Kingdom)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMORBIDITY; DEATH; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; HUMAN; KIDNEY DISEASE; LIVER DISEASE; META ANALYSIS; MORTALITY; NEOPLASM; PEPTIC ULCER BLEEDING; PREDICTION; PRIORITY JOURNAL; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; REVIEW; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; VALIDATION STUDY;

COMORBIDITY; HOSPITAL MORTALITY; HUMANS; PEPTIC ULCER HEMORRHAGE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84875213091     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.451     Document Type: Review

References (51)

1. Sung JJY, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of pepticulcer disease. Aliment Pharmacol Ther 2009; 29: 938-46.
2. Barkun A, Leontiadis G. Systematic review of the symptom burden, quality of life impairment and costs associated with pepticulcer disease. Am J Med 2010; 123: 358-66.e2.
3. Lau YJ, Sung J, Hill C et al. Systematic review of the epidemiology of complicated pepticulcer disease: incidence, recurrence, risk factors and mortality. Digestion 2011; 84: 102-13.
4. Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated pepticulcers in a Danish county 1993-2002: a populationbased cohort study. Am J Gastroenterol 2006; 101: 945-53.
5. Ramsoekh D, van Leerdam ME, Rauws EA et al. Outcome of pepticulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection. Clin Gastroenterol Hepatol 2005; 3: 859-64.
6. Rockall TA, Logan RF, Devlin HB et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996; 38: 316-21.
7. Barkun AN, Bardou M, Kuipers EJ et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010; 152: 101-13.
8. Laine L, Jensen DM. Management of patients with ulcer bleeding. Am J Gastroenterol 2012; 107: 345-60; quiz-61.
9. Ohmann C, Imhof M, Ruppert C et al. Time-trends in the epidemiology of pepticulcer bleeding. Scand J Gastroenterol 2005; 40: 914-20.
10. Bini EJ, Cohen J. Endoscopic treatment compared with medical therapy for the prevention of recurrent ulcer hemorrhage in patients with adherent clots. Gastrointest Endosc 2003; 58: 707-14.
11. Mose H, Larsen M, Riis A et al. Th irty-day mortality after pepticulcer bleeding in hospitalized patients receiving low-dose aspirin at time of admission. Am J Geriatr Pharmacother 2006; 4: 244-50.
12. Th omsen RW, Riis A, Christensen S et al. Diabetes and 30-day mortality from pepticulcer bleeding and perforation: a Danish population-based cohort study. Diabetes Care 2006; 29: 805-10.
13. Ahsberg K, Hoglund P, Stael von Holstein C. Mortality from pepticulcer bleeding: the impact of comorbidity and the use of drugs that promote bleeding. Aliment Pharmacol Ther 2010; 32: 801-1.
14. Rockall TA, Logan RF, Devlin HB, et al. Incidence of and mortality from acute upper gastro intestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. Br Med J 1995; 311: 222-6.
15. Bakkevold KE. Time trends in incidence of pepticulcer bleeding and associated risk factors in Norway 1985-2008. Clin Exp Gastroenterol 2010; 3: 71-7.
16. Loperfi do S, Baldo V, Piovesana E et al. Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc 2009; 70: 212-24.
17. Kang JY, Elders A, Majeed A et al. Recent trends in hospital admissions and mortality rates for pepticulcer in Scotland 1982-2002. Aliment Pharmacol Ther 2006; 24: 65-79.
18. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 2000; 356: 1318-21.
19. Sung J. Current management of pepticulcer bleeding. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 24-32.
20. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. 2011. Available: http://www.cochrane.org/training/ cochrane-handbook. Accessed 4 January-2013.
21. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006; 144: 427-37.
22. Palmer SC, Hayen A, Macaskill P et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 2011; 305: 1119-27.
23. Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J 2008; 336: 924-6.
24. Deeks J. When can odds ratios mislead? Odds ratios should be used only in case-control studies and logistic regression analyses. Br Med J 1998; 317: 1155-6; author reply 6-7.
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
26. Egger M, Davey Smith G. Principles of and procedure for systematic reviews. In: Egger M, Davey Smith G, Altman GA (eds). Systematic Reviews in Health Care: Meta-Analysis in Context. London, BMJ Publishing Group, 2001, pp 23-42.
27. The Cochrane Collaboration: Diagnostic Test Accuracy Working Group. Handbook for DTA Reviews. 2011. Available: http://www.srdta.cochrane. org/handbook-dta-reviews. Accessed 4 January-2013.
28. Leefl ang MM, Deeks JJ, Gatsonis C et al. Systematic reviews of diagnostic test accuracy. Ann Intern Med 2008; 149: 889-97.
29. Rutter CM, Gatsonis CA. A hierarchical regression approach to metaanalysis of diagnostic test accuracy evaluations. Stat Med 2001; 20: 2865-84.
30. Moayyedi P. Meta-analysis: can we mix apples and oranges? Am J Gastroenterol 2004; 99: 2297-301
31. Leontiadis GI, Sharma VK, Howden CW. Systematic review and metaanalysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay-results from the Cochrane Collaboration. Aliment Pharmacol Ther 2005; 22: 169-74.
32. Al-Akeely MH, Alam MK, Al-Salamah SM et al. Initial factors predicting rebleeding and death in bleeding pepticulcer disease. Saudi Med J 2004; 25: 642-7.
33. Bourienne A, Pagenault M, Heresbach D et al. Multicenter prospective study of prognostic factors of gastroduodenalulcer hemorrhages. Reevaluation of clinical and endoscopic factors in the era of endoscopic hemostasis. Gastroenterol Clin Biol 2000; 24: 193-200.
34. Branicki FJ, Coleman SY, Fok PJ et al. Bleeding pepticulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg 1990; 14: 262-269; discussion 9-70.
35. Brullet E, Calvet X, Campo R et al. Factors predicting failure of endoscopic injection therapy in bleeding duodenalulcer. Gastrointest Endosc 1996; 43: 111-6.
36. Chiu PW, Ng EK, Cheung FK et al. Predicting mortality in patients with bleeding pepticulcers after therapeutic endoscopy. Clin Gastroenterol Hepatol 2009; 7: 311-6; quiz-253.
37. Chow LW, Gertsch P, Poon RT et al. Risk factors for rebleeding and death from pepticulcer in the very elderly. Br J Surg 1998; 85: 121-4.
38. Christensen S, Th omsen RW, Torring ML et al. Impact of COPD on outcome among patients with complicated pepticulcer. Chest 2008; 133: 1360-6.
39. Hasselgren G, Carlsson J, Lind T et al. Risk factors for rebleeding and fatal outcome in elderly patients with acute pepticulcer bleeding. Eur J Gastroenterol Hepatol 1998; 10: 667-72.
40. Mueller X, Rothenbuehler JM, Amery A et al. Factors predisposing to further hemorrhage and mortality after pepticulcer bleeding. J Am Coll Surg 1994; 179: 457-61.
41. Nousbaum JB, Hochain P, Kerjean A et al. Hemorrhaging eso-gastro-duodenalulcers: epidemiology and management. A multicenter prospective study. Ann Chir 1999; 53: 942-8.
42. Qvist P, Arnesen KE, Jacobsen CD et al. Endoscopic treatment and restrictive surgical policy in the management of pepticulcer bleeding. Five years'experience in a central hospital. Scand J Gastroenterol 1994; 29: 569-76.
43. Soplepmann J, Peetsalu A, Peetsalu M et al. Pepticulcer haemorrhage in Tartu County, Estonia: epidemiology and mortality risk factors. Scand J Gastroenterol 1997; 32: 1195-200.
44. Sung JJ, Tsoi KK, Ma TK et al. Causes of mortality in patients with pepticulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol 2010; 105: 84-9.
45. Turner IB, Jones M, Piper DW. Factors influencing mortality from bleeding pepticulcers. Scand J Gastroenterol 1991; 26: 661-6.
46. Zaragoza AM, Tenias JM, Llorente MJ et al. Prognostic factors in gastrointestinal bleeding due to pepticulcer: construction of a predictive model. J Clin Gastroenterol 2008; 42: 786-90.
47. Hasselgren G, Blomqvist A, Eriksson S et al. Short and long term course of elderly patients with pepticulcer bleeding -analysis of factors influencing fatal outcome. Eur J Surg 1998; 164: 685-91.
48. Mueller X, Rothenbuehler JM, Amery A et al. Bleeding pepticulcer: an audit of conservative management. J Royal Soc Med 1994; 87: 132-4.
49. Hasselgren G, Lind T, Lundell L et al. Continuous intravenous infusion of omeprazole in elderly patients with pepticulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol 1997; 32: 328-33.
50. Kuipers EJ. Improved risk assessment in upper GI bleeding. Gastrointest Endosc 2011; 74: 1225-9.
51. Saltzman JR, Tabak YP, Hyett BH et al. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc 2011; 74: 1215-24.